Analytical performance evaluation of the new double-antibody sandwich Mindray total vitamin D assay and comparison vs. liquid chromatography tandem mass spectrometry
Abstract Objectives Measurement of total 25-hydroxyvitamin-D [25(OH)D] is widely used to assess vitamin D status, but immunoassays may show method-dependent differences related to calibration, analyte recognition, and metabolite effects. The new Mindray 25(OH)D assay is a noncompetitive chemiluminescent immunoassay based on an anti-metatype antibody design. Methods We evaluated calibration stability, precision, linearity, recovery, limit of quantification (LoQ), and potential effects of 24,25(OH)2D3, C3-epi-25(OH)D3 and 25(OH)D2. Serum and K 3 -EDTA plasma were compared in 150 paired samples. Comparison with a VDSP-certified LC-MS/MS was assessed in 146 serum samples. A regression derived recalibration equation was subsequently evaluated in an independent cohort of 115 samples. Results Total coefficients of variation (CVs) were 2.05–5.69 % across concentrations. Calibration remained within the predefined acceptance criteria for 31 days. The assay was linear from 3.92 to 136 μg/L (R 2 =0.9998), and the LoQ was 2.78 μg/L (CV=3.65 %). Mean recovery across 33 mixtures was 101.31 % (95 % CI, 100.47–102.15 %), with results ranging from 96.14 to 105.12 %. No clinically relevant effects of the investigated vitamin D metabolites were observed within the studied ranges. Serum and EDTA-plasma results were highly concordant. The CCC of the immunoassay vs. LC-MS/MS was 0.940, with a mean Bland–Altman difference of −2.5451 μg/L; after recalibration in the independent cohort, CCC increased to 0.995 and the mean difference was +0.0045 μg/L. Conclusions The Mindray assay showed excellent analytical performance over the evaluated range and matrices. Its initial difference from the LC-MS/MS method was reduced after regression recalibration. The findings emphasize the importance of reference-procedure alignment and verification of method bias at clinically relevant concentrations.
Authors
- Pierre Lukas (ORCID: https://orcid.org/0000-0002-1071-9057)
- Konstantinos Makris (ORCID: https://orcid.org/0000-0002-7896-9028)
- Efstathios Chronopoulos (ORCID: https://orcid.org/0000-0003-1667-9292)
- Ioulia Trifonidi (ORCID: https://orcid.org/0000-0002-3999-8459)
- Etienne Cavalier (ORCID: https://orcid.org/0000-0003-0947-2226)
Institutions
- University of Liège (BE)
- National and Kapodistrian University of Athens (GR)
- KAT General Hospital of Attica (GR)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1515/cclm-2026-1593
- Primary Topic
- Vitamin D Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00